Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
---|---|---|---|
USD 15.73 Billion | USD 73.41 Billion | 16.8% | 2024 |
FrequentlyAsked Questions
Epigenetics is the study of how gene expression is regulated without changing the actual DNA sequence.
In simpler terms:
? Your genes don’t change, but how active or inactive they are can change—based on environment, lifestyle, and other factors. That’s epigenetics
The global epigenetics market is expected to grow due to increasing research in gene expression, rising adoption of personalized medicine, and growing investments in epigenetic drug development.
According to a study, the global epigenetics market size was worth around USD 15.73 Billion in 2024 and is expected to reach USD 73.41 Billion by 2034.
The global epigenetics market is expected to grow at a CAGR of 16.8% during the forecast period.
North America is expected to dominate the epigenetics market over the forecast period.
Leading players in the global epigenetics market include Hologic Inc., Agilent Technologies Inc., Merck Millipore, PerkinElmer Inc., QIAGEN N.V., Illumina Inc., Thermo Fisher Scientific Inc., Abcam Plc., Zymo Research, and Active Motif Inc., among others., among others.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed